Numerous investigators have studied the reproductive and genetic toxicity of caffeine. Caffeine has also been reported to retard meiotic progression and induce aneuploidy in hamster oocytes in vitro. However, the ability of caffeine to induce aneuploidy in mammalian oocytes in vivo has not been reported. The objective of this study was to test the hypothesis that chemical-induced perturbations during in vivo oocyte meiotic maturation (OM) predispose oocytes to chromosome missegregation. Caffeine inhibits cAMP phosphodiesterase, which is needed for dephosphorylating p34 cdc2 kinase and initiating OM. Following superovulation, a dose of 150 mg/kg caffeine was administered to Institute of Cancer Research (ICR) female mice at various times prior to metaphase I (MI). Ovulated oocytes were collected from the oviducts and processed for cytogenetic analysis. Statistical analyses of the frequencies of hyperploid, MI, diploid, premature centromere separation and single chromatids revealed nonsignificant (P > 0.05) differences between the controls and each of the caffeine groups. Structural chromosome aberrations were not found. Under our experimental conditions, we rejected the hypothesis and concluded that caffeine neither retarded the rate of OM nor increased the incidence of aneuploidy in mouse oocytes. The factors responsible for the different in vivo and in vitro responses require investigation.
Introduction
Aneuploidy (an abnormal number of chromosomes involving single chromosomes) comprises the largest segment of human genetic disorders and accounts for considerable morbidity and mortality. Based upon the results from 10 surveys, the frequency of aneuploidy in human newboms is 0.31% (204/ 64887) (Hook, 1985) . In addition, -50% of spontaneous abortions are aneuploid (Bond and Chandley, 1983; Hecht and Hecht, 1987) and at least 10% of all human conceptions are trisomic or polyploid (Ford, 1981; Hansmann, 1983) . Since human aneuploidy is manifested as reproductive failure, spontaneous abortions, physical anomalies and mental retardation and is associated with some neoplastic tissues, the challenge to reduce the frequency of aneuploidy becomes apparent. Thus, information about the causes and mechanisms of aneuploidy production in mammalian germ cells in vivo is needed.
Unfortunately, we have little information about the etiologies of human aneuploidy. There are, however, two consistent findings: first, it is associated with advanced maternal age; and secondly, it occurs most often during maternal meiosis I (Hassold et al, 1984; Hassold, 1985) . Considerable research is needed to obtain information that can be used for understand-© UK Environmental Mutagen Society/Oxford University Press 1996 ing the etiology of aneuploidy. Such research involves developing and validating experimental models that can be used for identifying aneugens and investigating the mechanisms whereby aneuploidy is induced. Although various assays and models are being used for studying chemically induced aneuploidy, they have not been completely validated (Dellarco etai, 1986) .
Data pertaining to female germ cells are relatively sparse. Most of the available literature, including information about variables that influence the data from oocyte aneuploid assays, has been reviewed recently (Mailhes and Marchetti, 1994a; Mailhes, 1995) . An important point about the aneuploidy data for a specific chemical is that the results may differ between gender, cell type and assays. Therefore, extrapolating results between different sexes, cell types and assays requires caution. Such variation can be expected when considering the biochemical, physiologic and anatomic differences among cell types, plus the different experimental protocols utilized and the endpoints measured.
Another aspect of chemically induced aneuploidy is that different results are often found between in vivo and in vitro assays. For example, diazepam induces aneuploidy in vitro but not in somatic cells and female germ cells in vivo (Marchetti et al, 1994) . Such disparity may be largely influenced by differences in the pharmacokinetics (degree and rate of absorption, tissue distribution, metabolism and excretion) of a chemical. Unfortunately, relevant information about the pharmacokinetics of a compound in experimental animals is often unavailable. Consequently, a chemical reported as 'negative' in an in vivo assay may never have reached the target cells in a sufficient quantity to produce an observable cytogenetic alteration.
The objective of this study was to test the general hypothesis that perturbations induced during the normal time course of oocyte meiotic maturation (OM) predispose the oocyte population to chromosome missegregation. Such perturbations could involve an increase or a decrease (or both) in the rate of OM resulting from endogenous changes (gamete ageing, hormonal disequilibrium, etc.) or exogenous changes (chemicals, radiation, etc.). These alterations may disrupt the temporal sequence of interrelated processes that are essential for normal nuclear and cytoplasmic maturation and may predispose oocytes to aneuploidy (Hansmann and Pabst, 1992; EichenlaubRitter, 1994; Mailhes et al, 1995) .
We selected caffeine as a potential agent for perturbing OM because it competitively inhibits cAMP phosphodiesterase (Butcher and Sutherland, 1962; Timson, 1977) , which is needed for dephosphorylating p34 cdc2 kinase and initiating OM (Schultz et al, 1983; Schultz, 1988; Downs et al, 1989; Racowsky, 1991; Racowsky, 1993a, b; Chesnel et al, 1994) . In fact, most of caffeine's pharmacologic action is mediated by increasing the level of intracellular cAMP (Drug Information, 1994) . Aeschbacher et al. (1978) administered 100 mg/kg caffeine to mice p.o. daily for 1 or 8 weeks. They found that the maximum concentration of caffeine in testicular tissue was <10 ^g/g and that the half-life (2.5-3 h) of caffeine was similar between plasma and testicular tissue. Based upon in vivo data from two patients, Goldstein and Warren (1962) reported that caffeine equilibrates freely between plasma, ovaries and testes of humans. Thus, the possibility exists that a sufficient dose of caffeine may reach the mouse oocyte.
Several reviews (Mohr et al, 1993; D'Ambrosio, 1994; Nehlig and Debry, 1994) have shown that caffeine is mutagenic and clastogenic in bacteria, fungi and mammalian cells in vitro. Both synergistic and antagonistic effects of caffeine with known mutagens have been reported. On the other hand, dissimilar results were reported from in vivo studies. Information about caffeine-induced numerical and structural chromosome aberrations in mammalian oocytes in vivo has not been found.
Other information relevant to the objective of this study is that caffeine treatment in vitro caused the detachment of kinetochores from mammalian chromosomes (Brinkley et al, 1988; Zinkowski et al, 1989) and that caffeine induced a dose-dependent decrease in the rate of meiotic progression and an increase in the proportions of diploid and aneuploid metaphase II (MO) hamster oocytes in vitro (Prather and Racowsky, 1992) . Jagiello et al. (1972) reported that an acute dose of 0.25 mg caffeine/g body wt inhibited induced ovulation in mice. On the other hand, when ova were cultured in media containing different concentrations (25-5000 |ig/ml) of caffeine, these investigators found that doses >450 ng/ml prevented oocyte maturation and that cytogenetic aberrations were not detected in the lower doses. Besides testing hypotheses relevant to potential mechanisms for aneuploidy, data from in vivo studies are also needed to estimate the degree of human risk from caffeine-induced aneuploidy.
Various compounds such as cAMP analogs, cAMP phosphodiesterase inhibitors, hormones, protein synthesis inhibitors, phorbol esters, purines, prostaglandins, growth factors, calcium, calmodulin, forskolin and others can alter the normal progression of OM (Downs et al, 1989; Racowsky, 1991 Racowsky, , 1993a . Additional information about the potential relationship 396 between perturbations during OM and abnormal chromosome segregation can be found in Mailhes (1995) . We tested the hypothesis that caffeine induces a delay during OM that predisposes oocytes to chromosome missegregation in vivo.
Materials and methods

Animals, hormones and chemical treatment
Virgin, female ICR (Harlan Sprague-Dawley) mice 8-12 weeks of age (25-36 g body wt) were maintained under a 12 h light (0600-1800 h) and 12 h dark photoperiod with a room temperature between 21° and 23°C and relative humidity of 50 ± 5%. Teklad 22/5 rodent diet (W) #8640 (Harlan-Teklad Inc., Winnfield, IA) and water were provided ad libitum.
The number of maturing ovarian follicles was augmented by an i.p. injection of 7.5 IU pregnant mare's serum (PMS; Folligon batch #23521B; Intervet, Cambridge, UK). Ovulation was induced by an i.p. injection of 5.0 IU human chorionic gonadotrophin (HCG; lot #3921145 Ayerst Laboratories Inc., New York) 48 h after PMS.
Caffeine (1,3,7-trimelhylxanthine; CAS #58-08-2) was obtained from Sigma Chemical Co. (St Louis, MO; #C-O750). Based upon data from our preliminary toxicity experiments, the reported LDJO for an i.p. injection to mice of 168 mg/kg (Senda and Hirota, 1974) and the finding that 0.25 mg/g of caffeine blocked induced ovulation in mice (Jagiello et al., 1972) , we chose an acute dose of 150 mg/kg. This dose did not cause toxicity or lethality in any of the mice.
A 15 mg/ml DH2O solution was prepared within 90 min prior to injection. A dose of 150 mg caffeine/kg body wt (0.1 ml/10 g) was given by i.p. injection to different groups (each containing 10 females) at one of the following times relative to HCG: -4, -3, -2, -1, 0, +1, +2, +3, +4 or +5 h. The 10 different treatment times represent treatment prior to anaphase I (Eichenlaub-Ritter, 1993; Mailhes et al., 1993 Mailhes et al., , 1994 Marchetti and Mailhes, 1994) . This protocol insured that any aneuploidy detected in metaphase II (Mil) oocytes was actually induced during meiosis I. Also, since pharmacokinetic information about i.p. injections in mice was not found, these treatment times encompassed the spectrum of possible times, from the beginning of OM until MI, during which caffeine may interact with cAMP phosphodiesterase. The controls received 0.1 ml DH 2 0/10 g body wt (Abbott Laboratories, Chicago, IL; NDC 00744887-10) immediately after HCG.
Oocyte harvest and processing
Ovulated oocytes were collected 17 h post-HCG and processed for cytogenetic analysis (Mailhes and Yuan, 1987a) . This procedure involves harvesting oocytes en masse from ~10 females during a 3 h period. Thus, for each treatment group, oocytes were harvested on multiple days. 
Cytogenetic analysis and statistical analysis of data
When analyzing mouse Mil oocyte chromosomes for aneuploidy, it is essential to objectively distinguish between oocytes containing complete dyads (chromosomes) (Figure 1 ) and those containing single, unpaired chromatids (Figure 2 ). Such a distinction was attained by C-banding the chromosomes (Salamanca and Armendares, 1974) ; without C-banding a single chromatid may be mistakenly counted as a dyad, which has two chromatids. In each Mil oocyte analyzed, the number of dyads and/or chromatids was counted at X1250 magnification to determine the frequency of aneuploidy. The number of hypoploid (n = 10-19.5), haploid (n = 20), hyperploid (n = 20.5-29.5) and diploid cells (n = 30-40) (Figure 3 ) was recorded. Mil oocytes containing single chromatids (SC) such as those with 20 dyads and one chromatid (n = 20.5) were classified as hyperploid. The frequencies of each ploidy class were divided by the total number of Mil cells analyzed excluding diploidy. Since Ml and diploid Mil oocytes were not analyzed for aneuploidy and were distinct categories, their frequencies were calculated relative to the total number of oocytes analyzed.
The classes of abnormalities involving oocytes with premature centromere separation (PCS), both partial ( Figure 4 ) and complete ( Figure 5 ), were noted. We routinely record these classes because they have been shown to increase with harvest time postovulation or postovulatory ageing (Mailhes and Marchetti, 1994b) . The number and type of structural chromosome aberrations were also recorded when present.
For calculating aneuploidy, the frequencies of hyperploidy in the different experimental groups were used. This is a common practice because an unknown proportion of hypoploid cells is influenced by technical artifact resulting from excessive chromosome scatter when preparing slides. This does not imply that the hypoploidy data are unimportant; in fact, they are especially relevant for chromosome lagging events.
The following criteria were used for eliminating a cell from the analysis: inadequate C-banding to enable a distinction to be made between intact dyads and those separated at the centromere; overlapped or clumped chromosomes; or those with excessive chromosome scatter that precluded an objective analysis. Fisher's exact test was used for the statistical analysis of data.
Results
Prior to beginning the cytogenetic study, preliminary experiments were performed to establish the times for treatment and cell harvest, and a non-toxic dose of caffeine. If an animal exhibited any sign of toxicity (or lethality) within 48 h following caffeine treatment, we reduced the dose until one was found that was non-toxic. We found that 150 mg/kg was an appropriate, non-toxic dose. The results from the preliminary experiments and the suggested dose-setting guidelines for in vivo mutagenic experiments (Fielder et ah, YW1; Mackay and Elliott, 1992) were used to design the protocol for the cytogenetic study. Table I contains the oocyte cytogenetic data from mice given 150 mg/kg caffeine at different preovulatory times.
Statistical analyses of the hyperploidy, SC and PCS data indicated non-significant (P > 0.05) differences between the control group and each of the treated groups or all treated groups combined. Although the frequencies of hypoploidy were greater in each of the caffeine-treated groups relative to controls, only those found in the -4, -3, 0, +1, +3 and +4 h groups were significantly different (P < 0.05, Fisher's exact test) from the controls. These findings do not reflect an overall trend in hypoploidy frequencies as a function of treatment time. However, as mentioned earlier, the biological significance of hypoploidy as an indicator of aneuploidy is confounded by technical artifact. Both ovulated MI and diploid Mil oocytes have been shown to be positively correlated with chemically induced meiotic delay (Russo and Pacchierotti, 1988; Tiveron et al, 1992; Mailhes and Marchetti, 1993, 1994a; Mailhes et al, 1993) . Since the frequencies of ovulated MI and diploid MH oocytes were not significantly (P < 0.05) increased by caffeine, we conclude that the rate of OM was not delayed. Structural chromosome aberrations were not observed.
Discussion
An objective of this study was to test the hypothesis that caffeine-induced perturbations during OM predispose oocytes to aneuploidy. Caffeine was chosen as the study compound because it competitively inhibits cAMP phosphodiesterase (Butcher and Sutherland, 1962) , which is needed for dephosphorylating certain proteins that are essential for OM. Also, caffeine has been shown to retard OM and to induce aneuploidy in hamster oocytes in vitro (Prather and Racowsky, 1992) . The statistical analyses of data revealed that caffeine neither induced a delay during OM, as detected by ovulated MI or diploid oocytes, nor induced aneuploidy in ICR mouse Mil oocytes. Thus, under the conditions of this in vivo study, we conclude that the results do not support the hypothesis.
Although our results differ from those of an in vitro study of caffeine-induced aneuploidy in hamster oocytes (Prather and Racowsky, 1992) , our findings do agree with an in vitro study of mouse oocytes (Jagiello et al, 1972) and an in vivo study involving mouse MI spermatocytes following chronic caffeine ingestion (Adler and Rohrborn, 1969) . In male mice, caffeine does not accumulate in testicular tissue (Aeschbacher et al, 1978) . Thus, the possibility exists that the in vivo phannacokinetics of caffeine in mice is such that a sufficient dose did not reach the ovarian follicles due either to catabolism or elimination.
Nevertheless, our results do point out an important issue involving both germ and somatic cells-namely, that differences exist between the results from in vivo and in vitro assays. Since a multitude of in vitro genetic toxicology assays are being used for identifying aneugens and mutagens, the question of their relevance to in vivo reproductive genetic risk becomes apparent. Besides the virtual unknown applicability of most in vitro reproductive genetic data to humans, these assays, however, do offer advantages for investigating certain mechanisms of aneuploidy induction.
Based upon our results, we conclude that 150 mg/kg caffeine does not significantly induce cytogenetic damage in ICR mouse oocytes in vivo. Apart from our findings, other studies are needed to investigate the degree to which the results from in vitro studies can reliably predict the in vivo situation when the objective is to identify mutagens and aneugens to which humans may be exposed.
Another area in which more information is needed is the phannacokinetics of compounds used for in vivo studies. Such information would reduce the need for multiple treatment times, which are used to blanket the period from the initiation of OM to MI. Earlier studies (Mailhes and Yuan, 1987b; Mailhes et al, 1993) have shown that the preovulatory time of chemical treatment influences the frequency of aneuploid Mil mouse oocytes. Due to the multiple targets associated with aneuploidy production and the pharmacokinetic differences between chemicals, a single treatment time for oocyte aneuploidy studies seems unrealistic. In essence, the biology of the cell and the pharmacokinetics of the compound being studied should dictate the experimental design. The presence of single chromatids in Mil oocytes is thought to originate from predivision or premature separation of the homologous chromatids of a dyad during meiosis I. In addition to nondisjunction of homologous chromosomes, predivision of dyads may also be a significant cause of human trisomy (Mailhes, 1987; Angell, 1991) . Although the frequencies of oocytes with SC were not significantly (P < 0.05) increased following caffeine treatment, the association of this variable with aneuploidy production requires additional study.
Our finding that the frequency of oocytes with PCS was not elevated following caffeine is not surprising considering that cells were harvested at only one time postovulation. Excluding parthenogenesis, this variable seems to be mainly influenced by postovulatory ageing (Mailhes and Marchetti, 1993,1994a) . Nevertheless, this is a cytogenetic abnormality that deserves more attention because it may be associated with missegregation during anaphase II and the presence of aneuploidy in the zygote. If the chromatids of homologous chromosomes have segregated prior to anaphase, as in PCS MH oocytes, the chromatids would be expected to segregate randomly during anaphase II. Such a situation would greatly increase the probability of homologous chromatids going to the same pole.
In conclusion, 150 mg/kg caffeine administered i.p. to ICR mice did not result in recognized meiotic delay or elevated frequencies of cytogenetic aberrations during OM. Our results differ from those following in vitro exposure of hamster oocytes to caffeine (Prather and Racowsky, 1992) . Besides possible species differences, we believe that the in vivo pharmacokinetics of caffeine resulted in an insufficient exposure of the oocyte population to detect any increase in the parameters measured. A direct effect of this study is to reemphasize that differences exist between in vivo and in vitro reproductive genetic studies and that the reasons and mechanisms responsible for such differences require investigation.
